Improving glycemic and cholesterol control through an integrated approach incorporating colesevelam – a clinical perspective

Bile sequestrants have been used for almost 50 years to lower low density lipoprotein cholesterol (LDL-C). The advent of colesevelam in 2000 provided a more tolerable add-on LDL-C-lowering agent with an excellent safety record and with likely benefit for coronary heart disease events. Colesevelam lo...

Descripción completa

Detalles Bibliográficos
Autor principal: Goldberg, Ronald B
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048018/
https://www.ncbi.nlm.nih.gov/pubmed/21437115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048018/
https://www.ncbi.nlm.nih.gov/pubmed/21437115

Ejemplares similares